Načítá se...
Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy
Many women experience bothersome vasomotor and vaginal symptoms during the menopausal transition. Decreasing levels of estrogens during menopause are also associated with reduced bone density and an increased risk of osteoporosis. Combined estrogen/progestin therapy (hormone therapy) effectively tre...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3325004/ https://ncbi.nlm.nih.gov/pubmed/22505832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJWH.S29346 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|